Celgene Tumbles As Top Bristol Shareholder Opposes $74 Billion Merger [Investor's Business Daily]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Investors Business Daily
Related news 4:21 PM ET Sarepta Therapeutics stock jumped closer to a breakout Wednesday after its gene therapy showed promise in a form of limb-girdle... Biotech Stocks To Watch And Pharma Industry News Roche Is Buying Spark — Now These Other Gene Therapy Stocks Are In Play Which Pharmaceutical Stocks Are Outperforming All Other Stocks? The Top 5 Biotech Stocks Are Facing Growth Challenges — Are Any Immune? Stock Upgrades: Spark Therapeutics Shows Rising Relative Strength This Is One Company That Could Break Up Bristol-Celgene Deal Highly Rated Biotech Turns Profitable — But Earnings Lag Estimates Teva Expects To Hit Bottom In 2019 — Stock Dives On Lagging Outlook Celgene stock plunged late Wednesday after Bristol-Myers Squibb 's ( BMY ) top shareholder said it opposes the $74 billion merger of the two biopharma giants. Wellington Management Company, which owns 8% of Bristol stock, agrees the drug giant should be seeking mergers and partners
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off [Seeking Alpha]Seeking Alpha
- Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat [Yahoo! Finance]Yahoo! Finance
- Why Bristol Myers Squibb Stock Is Sinking Today [Yahoo! Finance]Yahoo! Finance
- Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 4/25/24 - Miss
BMY
Sec Filings
- 4/25/24 - Form 10-Q
- 4/25/24 - Form 8-K
- 4/22/24 - Form DEFA14A
- BMY's page on the SEC website